Luis Paz‐Ares

Researcher Next ID · RN-002827

Researcher · Medicine

Madrid, Spain

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Lung Cancer Diagnosis and Treatment

Peptidase Inhibition and Analysis

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1810865
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709937
Lung cancer: current therapies and new targeted treatments
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30958-8
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504627
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70393-x

No projects listed.